AUTHOR=Sawaguchi Yuichi , Yamazaki Ryuta , Nishiyama Yukiko , Mae Masayuki , Abe Atsuhiro , Nishiyama Hiroyuki , Nishisaka Fukiko , Ibuki Tatsuya , Sasai Toshio , Matsuzaki Takeshi TITLE=Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities JOURNAL=Frontiers in Pharmacology VOLUME=12 YEAR=2021 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.672536 DOI=10.3389/fphar.2021.672536 ISSN=1663-9812 ABSTRACT=
Pim kinases are overexpressed in various types of hematological malignancies and solid carcinomas, and promote cell proliferation and survival. Here in this study, we investigated the preclinical profile of novel pan-Pim kinase inhibitors with imidazopyridazine and thiazolidinedione structure. Imidazopyridazine-thiazolidinediones inhibited activities of Pim kinases with IC50 values of tens to hundreds nanomolar. With YPC-21440 and/or YPC-21817, which exhibited especially high inhibitory activities against Pim kinases, we investigated